Polyphenols and neuroprotection: Therapeutic implications for cognitive decline

G Caruso, SA Torrisi, MP Mogavero, W Currenti… - Pharmacology & …, 2022 - Elsevier
Dietary polyphenols have been the focus of major interest for their potential benefits on
human health. Several preclinical studies have been conducted to provide a rationale for …

[HTML][HTML] The safety of green tea and green tea extract consumption in adults–results of a systematic review

J Hu, D Webster, J Cao, A Shao - Regulatory toxicology and pharmacology, 2018 - Elsevier
A systematic review of published toxicology and human intervention studies was performed
to characterize potential hazards associated with consumption of green tea and its …

Down syndrome and the complexity of genome dosage imbalance

SE Antonarakis - Nature Reviews Genetics, 2017 - nature.com
Down syndrome (also known as trisomy 21) is the model human phenotype for all genomic
gain dosage imbalances, including microduplications. The functional genomic exploration of …

Green tea effects on cognition, mood and human brain function: A systematic review

E Mancini, C Beglinger, J Drewe, D Zanchi, UE Lang… - Phytomedicine, 2017 - Elsevier
Abstract Background Green tea (Camellia sinensis) is a beverage consumed for thousands
of years. Numerous claims about the benefits of its consumption were stated and …

Scientific opinion on the safety of green tea catechins

EFSA Panel on Food Additives and Nutrient … - EFSA …, 2018 - Wiley Online Library
Abstract The EFSA ANS Panel was asked to provide a scientific opinion on the safety of
green tea catechins from dietary sources including preparations such as food supplements …

DYRK1A inhibitors for disease therapy: Current status and perspectives

T Liu, Y Wang, J Wang, C Ren, H Chen… - European journal of …, 2022 - Elsevier
Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a conserved
protein kinase that plays essential roles in various biological processes. It is located in the …

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo …

R de la Torre, S de Sola, G Hernandez, M Farré… - The Lancet …, 2016 - thelancet.com
Background Early cognitive intervention is the only routine therapeutic approach used for
amelioration of intellectual deficits in individuals with Down's syndrome, but its effects are …

Modulation of neurotrophic signaling pathways by polyphenols

F Moosavi, R Hosseini, L Saso… - Drug design, development …, 2015 - Taylor & Francis
Polyphenols are an important class of phytochemicals, and several lines of evidence have
demonstrated their beneficial effects in the context of a number of pathologies including …

Dementia in Down's syndrome

C Ballard, W Mobley, J Hardy, G Williams… - The Lancet …, 2016 - thelancet.com
Down's syndrome is the most common genetic cause of learning difficulties, and individuals
with this condition represent the largest group of people with dementia under the age of 50 …

Emerging evidence for astrocyte dysfunction in schizophrenia

EC de Oliveira Figueiredo, C Calì, F Petrelli, P Bezzi - Glia, 2022 - Wiley Online Library
Schizophrenia is a complex, chronic mental health disorder whose heterogeneous genetic
and neurobiological background influences early brain development, and whose precise …